National Bank Of Canada Seagen Inc. Transaction History

National Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$191.51 - $216.16 $1.14 Million - $1.29 Million	5,959 Added 9.28%	70,170 $14.9 Million
Q2 2023 Jul 26, 2023	BUY	$187.64 - $206.25 $7.14 Million - $7.85 Million	38,071 Added 145.64%	64,211 $12.4 Million
Q1 2023 Apr 12, 2023	SELL	$127.59 - $203.08 $19.4 Million - $30.9 Million	-152,173 Reduced 85.34%	26,140 $5.29 Million
Q4 2022 Jan 24, 2023	BUY	$117.37 - $139.17 $17.5 Million - $20.8 Million	149,346 Added 515.57%	178,313 $0
Q3 2022 Oct 13, 2022	SELL	$135.27 - $180.11 $690,012 - $918,741	-5,101 Reduced 14.97%	28,967 $3.91 Million
Q2 2022 Jul 28, 2022	SELL	$108.81 - $179.33 $252,439 - $416,045	-2,320 Reduced 6.38%	34,068 $6.12 Million
Q1 2022 May 05, 2022	BUY	$119.61 - $157.85 $1.48 Million - $1.96 Million	12,389 Added 51.62%	36,388 $5.24 Million
Q4 2021 Jan 24, 2022	BUY	$142.57 - $190.86 $3.42 Million - $4.58 Million	23,999 New	23,999 $3.67 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.